CVS Group Plc
("CVS" or the "Company")
Long Term Incentive Plan Award
CVS, one of the UK's leading providers of integrated veterinary services, announced on 9 November 2020 that it had granted option awards over a total of 136,485 of the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") under the CVS Group Long Term Incentive Plan 2020 ("LTIP 14") (the "Options").
Certain of the awards made have subsequently been adjusted, in accordance with the Group's remuneration policy. The resulting total number of Ordinary Shares over which options have been granted under LTIP14 is now 143,218. Vesting conditions relating to LTIP 14 are unchanged.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail with regard to the additional award to one Director.
Contacts:
CVS Group Plc Tel: 01379 644288
Richard Fairman, Chief Executive Juliet Dearlove, Company Secretary
N+1 Singer (Nominated Adviser and Broker) Tel: 020 7496 3000
Aubrey Powell (Corporate Finance)
Rachel Hayes (Corporate Broking)
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Robin Alfonso |
|
|
|
| |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Chief Financial Officer | |||
| b) | Initial notification /Amendment | Initial Notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | CVS Group plc | |||
| b) | LEI | 213800J41XDQ2NX48O05 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 0.2 pence each
GB00B2863827 | |||
| b) | Nature of the transaction | Grant of options under LTIP 14 | |||
| c) | Price(s) and volume(s) |
| |||
|
| Price(s) | Volume(s) |
| ||
| Exercise price of 0.2p | 6,733 |
| |||
| d) | Aggregated information
- Aggregated volume
- Price |
| |||
| e) | Date of the transaction | Award made on 4 January 2021 | |||
| f) | Place of the transaction | Off market | |||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
